IL17A and inflammatory bowel disease: The decrease in IL-17 expression might be an important contributor to the ameliorative effect of L. acidophilus on the pathogenesis of colitis as observed in our previous report [20], because inhibition of IL-17 function with a chemical inhibitor or anti-IL-17 antibody has been extensively demonstrated to be effective in IBD treatment [28–30].